Actavia Life Sciences
RASP · OTC
$0.0005−$0.0095 (−95.00%)TodayMarket closed ·
No price history for this range.
Key indicators
RASP profitability and balance sheet ratios
Return on equity -0.3% in Mar 2020, up 0.4 points on a year earlier.
| Period | Return on equity |
|---|---|
| Jun 2018 | -1.2% |
| Sep 2018 | -1.0% |
| Dec 2018 | -0.8% |
| Mar 2019 | -0.6% |
| Jun 2019 | -0.5% |
| Sep 2019 | -0.4% |
| Dec 2019 | -0.3% |
| Mar 2020 | -0.3% |
Income statement
No financial statements are reported for Actavia Life Sciences.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| Total assets | $0.1M | $0.0M | $0.0M |
| Total liabilities | $2.1M | $2.1M | $2.2M |
| Shareholder equity | −$2.0M | −$2.1M | −$2.2M |
| Cash and short-term investments | $0.1M | $0.0M | $0.0M |
| Total debt | $0.2M | $0.2M | $0.3M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.